Mauro Gitto
@mauro_gitto
Followers
215
Following
491
Media
3
Statuses
91
MD, Research Fellow at @IcahnMountSinai Cardiology Resident at @HumanitasMilano
Milano, Lombardia
Joined November 2013
Are GLP-1 receptor agonists plaque modifiers? 🫀 In diabetic ACS patients, 1-year GLP-1RA therapy led to significant plaque regression and metabolic reprogramming. Preliminary evidence just published ⬇ 🔗 https://t.co/EPtjG38EB0
@mauro_gitto @HumanitasMilano
link.springer.com
Acta Diabetologica - Despite advances in therapeutic strategies a significant proportion of acute coronary syndrome (ACS) patients experience early coronary artery disease (CAD) progression,...
0
1
4
A modern #PCI approach for #diffuse disease in a #calcific #LAD with a terrific final result!! Congrats @antocol171 @DamianoRegazzo1 @mauro_gitto
#JIMGISE2025
@jimcongress
@amrabbasmd @Dralkutshan @gioelsecco @AliceBen_90 @fra_giannini1 @DrAlexandreAbiz @MrcTsl @leoneppmd
0
10
28
#EAPCI/PCR Journal Club: A randomised trial of sirolimus- versus paclitaxel-coated balloons for de novo coronary lesions @mauro_gitto & @NicolaRyanI1 review ✍️this study which compares a novel sirolimus-coated with a clinically proven paclitaxel-coated 🎈 demonstrating
4
11
25
The #ACCBOT has approved the College's newest officers and trustees who will assume their roles in March 2025 following #ACC25 in Chicago, IL. Congratulations @ChrisKramerMD, @Drroxmehran, @SamOJonesMD and @garosemd! 🎉 Read more: https://t.co/WwfqQFdpxz
#ACCLeadership
14
23
76
Fantastic opportunity to present new #DCB 3.0 registry data from @HumanitasMilano Exciting sessions including: - Everolimus-eluting 🎈 - SCB vs. PCB - TRANSFORM I So much more coming! @Antocol17 @BernardCortese #BrunoScheller #PatrickSerruys #ManelSabatè
1
4
21
Thrilled to present the results of our study on #DCB based LAD PCI at #TCT2023 in San Francisco and to see the full paper simultaneously published on @CircIntv One more piece of evidence that supports the use of a #DCB based treatment for diffuse coronary artery disease.
DCB vs. DES for LAD PCI. A Featured Science Presentation @CRF #TCT2023 published simultaneously in https://t.co/XGSRacYI3Y.
https://t.co/YQD8yvwxVx
@mauro_gitto @Sticchi_Alex @ChiaritoMauro @Antocol17 #TCTConference #ACCFIT #AHAJournals
1
3
19
Take a look at our comprehensive review just out on @MyJSCAI! ➡️ https://t.co/LchZlFKviq
@GGStefanini @alaide_chief @AlexandraLansky
jscai.org
Dual antiplatelet therapy (DAPT) has been paramount in preventing thrombosis following percutaneous coronary intervention for nearly 3 decades. However, over the years, DAPT has seen significant...
Comprehensive guide to #DAPT in #PCI: past, present & future. Tailoring DAPT strategies to bleeding & ischemic risk. More to come on #ticagrelor #prasugrel in #ACS ➡️ https://t.co/n0Dskyfl6s
@AlexandraLansky @GGStefanini @mauro_gitto @alaide_chief
0
1
3
#RCM-Special Issue: Present and future of #tricuspid #regurgitation (1/5) 🚂Etiology, epidemiology, pathophysiology and management of tricuspid regurgitation: an overview @fracond_94 @mauro_gitto @GGStefanini
#tricuspidregurgitation #TR Full Text https://t.co/uD8cC517Cq
0
1
5
In the study by @MintenLennert, CAD presence and ⬆️ SS in TAVR candidates were associated with ⬆️ all-cause and CV death at 5y. However, PCI and completeness of revasc had no impact of mortality. Have a look at our editorial 👉 https://t.co/AwDLBcv6oQ
@GGStefanini @JACCJournals
1
6
19
Biochemical efficacy of #SGLT2 inhibitors by cardiovascular risk profile and volume status in a real-world diabetic population. Just accepted in @JCVPOnline. Take a look!
Benefits of SGLT2 inhibitors in a real-world diabetic population https://t.co/ZWIOzpcrMl
@mauro_gitto @GGStefanini @gcondorelli @HumanitasMilano @HUNIMED
#EMPA #CANVAS #DECLARE #SGLT2 #HbA1 #kidney #infection #glycemia #clinicaltrials #diabetes
0
0
1
ICYMI
The integration of automated tools may provide a more accurate estimate of coronary stenosis in women with ischemic heart disease, research by @sealtin1 and @mauro_gitto in @InvasiveCardiol suggests. Learn about the WOMEN FiRST trial: https://t.co/ToLge97WdL
@YaleMed @YaleIMed
0
3
9
Such a great honor to be part of this amazing trial! Check out our published work👇🏻 #WOMEN_FiRST @sealtin1 @mauro_gitto @YaleCardiology #CardioTwitter
The integration of automated tools may provide a more accurate estimate of coronary stenosis in women with ischemic heart disease, research by @sealtin1 and @mauro_gitto in @InvasiveCardiol suggests. Learn about the WOMEN FiRST trial: https://t.co/ToLge97WdL
@YaleMed @YaleIMed
2
4
16
Congrats @sealtin1 @mauro_gitto @RoyTaoutel on an important and timely publication . Wire free assessment always preferred when one wire perf/dissection is seen in real time. @mirvatalasnag @BinitaShahMD @biljana_parapid @avolgman @JDawnAbbott1 @saraceciliamtz @sandylewis
Congratulations to our team @mauro_gitto @RoyTaoutel and the YCRG core lab for using novel QFR in women with stable coronary syndromes. Novel wire free assessments of coronary hemodynamics are powerful.
1
1
5
Congratulations to our team @mauro_gitto @RoyTaoutel and the YCRG core lab for using novel QFR in women with stable coronary syndromes. Novel wire free assessments of coronary hemodynamics are powerful.
The integration of automated tools may provide a more accurate estimate of coronary stenosis in women with ischemic heart disease, research by @sealtin1 and @mauro_gitto in @InvasiveCardiol suggests. Learn about the WOMEN FiRST trial: https://t.co/ToLge97WdL
@YaleMed @YaleIMed
1
6
17
0
0
1
Comparison of #QCA, #QFR and visual assessment (VA) in #women with stable CAD: -> ⬆️ %DS at VA vs. QCA -> ⬆️ discrepancy observed in angiographically severe lesions -> 1/3 of severe lesions at angiography had QFR >0.8 Read the full manuscript at
The integration of automated tools may provide a more accurate estimate of coronary stenosis in women with ischemic heart disease, research by @sealtin1 and @mauro_gitto in @InvasiveCardiol suggests. Learn about the WOMEN FiRST trial: https://t.co/ToLge97WdL
@YaleMed @YaleIMed
1
3
9
🫀Left anterior descending coronary artery occlusion after balloon aortic valvuloplasty Read at https://t.co/EO9T1aPeQC
#cardiology #interventionalcardiology #cardiologyfellow #cardiologia #echocardiography #cathlab #ECG #cardiovascular #electrocardiography #cardiac #ITcardiology
0
4
9
🎄🔊#RCM - Vol. 22 No. 4 (6/62) 💎Review #Etiology, #epidemiology, #pathophysiology and management of #TricuspidRegurgitation: an overview @fracond_94 @GGStefanini @mauro_gitto
https://t.co/h6q4lTb5K1
0
6
6